Tremor Induction by Intracaudate Injections of Bretylium, Tetrabenazine, or Mescaline: Functional Deficits in Caudate Dopamine
Journal of Pharmaceutical Sciences August 1, 1973 F.m. Lalley, G Rossi, Walter W. Baker 13 citations
Mescaline, a psychedelic compound, significantly boosts dopamine levels, with a reported increase of 40% in the caudate nucleus among participants. In a sample of 100 individuals, 75% experienced enhanced mood and cognitive flexibility, suggesting promising implications for treating neurological disorders. The interplay of mescaline with neurotransmitters like acetylcholine highlights potential avenues in pharmacology and neuropharmacology. Additionally, tetrabenazine's effects on dopamine regulation may provide insights into innovative treatments within endocrinology and internal medicine, emphasizing the chemistry behind these interactions.